Author

Elisabeth Brown

University of Utah

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alana L. WelmiD· 1 shared Apurva Srivastava· 1 shared Bryan Welm· 1 shared Chieh-Hsiang Yang· 1 shared Emilio Cortes Sanchez· 1 shared Hui YangiD· 1 shared Jaime Fornetti· 1 shared Paige Jensen· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alana L. WelmORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Response to SMAC mimetics in patient-derived models of triple-negative breast cancer relies on RIPK1 activation

Elisabeth Brown, Paige Jensen, Chieh-Hsiang Yang, Emilio Cortes Sanchez, Zhengtao Chu, Hui Yang, Yi Qiao, 義行高橋, Apurva Srivastava, Bryan Welm, Jaime Fornetti, Alana L. Welm

This study identifies RIPK1 activation as a key determinant of response to SMAC mimetics in TNBC, showing that resistance is linked to impaired RIPK1 autophosphorylation and HOIP overexpression.

bioRxiv · Oct 28, 2026 · PreprintCancer Biology